Traffic Roots Audience Pixel

Benzinga Psychedelics
Advisory Council

meet our

COUNCIL BOARD MEMBERS

Amanda Siebert
Amanda Siebert

Author, Journalist, Photographer, Host

Andrew Chadeayne
Andrew Chadeayne

Founder & CEO
Caamtech

Anne Donohoe
Anne Donohoe

Managing Director
KCSA Strategic Communications

Berner
BERNER

Co-Founder & CEO
Cookies

Bia Labate, Ph.D
Bia Labate, Ph.D

Executive Director
Chacruna Institute for Psychedelic Plant Medicines

Bryan Passman
Bryan Passman

Co-Founder & Head Hunter
Hunter + Esquire

Doug Drysdale
Doug Drysdale

CEO
Cybin Inc.

Florian Brand
Florian Brand

Co-Founder & CEO
ATAI Life Sciences

Graham Pechenik
Graham Pechenik

Patent Attorney & Founder
Calyx Law

Joseph Tucker
Joseph Tucker

CEO
Enveric Biosciences

Kathryn Walker
Kathryn Walker

CEO
Revitalist Lifestyle and Wellness

Kelsey Ramsden
Kelsey Ramsden

Entrepreneur

Lauren Taus
Lauren Taus

Psychedelic Assisted Therapist
Inbodied Life

Lindsay Hoover
Lindsay Hoover

Co-Founder & Managing Partner
JLS Fund

Maria Velkova
Maria Velkova

Managing Partner
Tabula Rasa Ventures

Najla Guthrie
Najla Guthrie

CEO
Wellbeing Digital Sciences

Natalie Lyla Ginsberg
Natalie Lyla Ginsberg

Global Impact Officer
Multidisciplinary Association for Psychedelic Studies, (MAPS)

Natan Ponieman
Natan Ponieman

Writer/Editor
Benzinga

Payton Nyquvest
Payton Nyquvest

Founder & CEO
Numinus

Professor David Nutt, an advisory board member of the Benzinga Psychedelics Capital Conference
Professor David Nutt

Chief Research Officer; The Edmond J Safra Chair in Neuropsychopharmacology
Awakn Life Sciences; Imperial College London

Robert Barrow
Rob Barrow

CEO
MindMed

Ronan Levy
Ronan Levy

Co-Founder & Executive Chairman
Field Trip Health

Simeon Schnapper
Simeon Schnapper

Managing Partner
JLS Fund

Tim Regan
Tim Regan

SVP Capital Markets
KCSA Strategic Communcations

Timothy Schlidt
Timothy Schlidt

Co-Founder & Partner
Palo Santo Fund

Zappy Zapolin
Zappy Zapolin

Futurist and Psychedelic Industry Thought Leader

Buy Tickets today!